The Human Thrombin Receptor Gene and the 5q-Syndrome

References

• Berghe Van Den H., Cassiman J. J., David G., Fryns J. P., Michaux J. L., Sokal G. Distinct haematological disorder with deletion of long arm of number 5 chromosome. Nature 1974; 251: 437–438
   PubMed Web of Science ®Google Scholar
• Boultwood J., Lewis S., Wainscoat J. S. The 5q-syndrome. Blood 1994; 84: 3253–3260
   PubMed Web of Science ®Google Scholar
• Nagarajan L. Molecular analysis of the 5q-chromo-some. Leukemia and Lymphoma 1995; 17: 361–366
   PubMed Web of Science ®Google Scholar
• Mathew P., Tefferi A., Dewald G. W., Goldberg S. L., Su J., Hoagland H. C., Noel P. The 5q-syndrome: A single-institution study of 43 consecutive patients. Blood 1993; 81: 1040–1045
   PubMed Web of Science ®Google Scholar
• Willman C. L., Sever C. E., Pallavicini M. G., Harada H., Tanaka N., Slovak M. L., Yamamoto H., Meeker T. C., List A. F., Taniguchi T. Deletion of IRF-l, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968–971
   PubMed Web of Science ®Google Scholar
• Nagarajan L., Zavadil J., Claxton D. F., Xiaoyan L., Fairman J., Warrington J. A., Wasmuth J. J., Chinault A. C., Sever C. E., Slovak M. L., Willman C. L., Deisseroth A. B. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-l in patients with 5q-chromosome. Blood 1994; 83: 199–208
   PubMed Web of Science ®Google Scholar
• LeBeau M. M., Espinosa R., III, Neuman W. L., Stock W., Roulston D., Larson R. A., Keinanen M., Westbrook C. A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proceedings of the Notional Academy of' Sciences USA 1993; 90: 5484–5488
   PubMed Web of Science ®Google Scholar
• Boultwood J., Fidler C., Lewis S., Kelly S., Sheridan H., Littlwood T. J., Buckle V. J., Wainscoat J. S. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: delineation of the critical region on 5q and identification of a 5q-breakpoint. Genomics 1994; 19: 425–432
   PubMed Web of Science ®Google Scholar
• Dohlman H., Thorner J., Caron M., Lefkowitz R. Model systems for the study of seven-transmembrane-segment receptors. Annual Review of Biochemistry 1991; 60: 653–688
   PubMed Web of Science ®Google Scholar
• Vu T., Hung D., Wheaton V., Coughlin S. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057–1068
   PubMed Web of Science ®Google Scholar
• Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Molecular cloning of a potential proteinase activated receptor. European Journal of Biochemistry 1994; 91: 9208–9212
   Google Scholar
• Vu T., Wheaton V., Hung D., Charo L, Coughlin S. Domains specifying thrombin-receptor interaction. Nature (London) 1991; 353: 674–677
   PubMed Web of Science ®Google Scholar
• Chen J., Ishii M., Wang L., Ishii K., Coughlin S. R. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. Journal of Biologicul Chemistry 1994; 269: 16041–16045
   PubMed Web of Science ®Google Scholar
• Vouret-Craviari V., Van Obberghen-Schilling E., Rasmussen V., Pavirani A., Lecocq J., Pouyssegur J. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unahle to induce mitogenesis. Molecular Cell Biology 1991; 3: 95–102
   Google Scholar
• McGowan E., Detwiller T. Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms. Journal of Biological Chemistry 1987; 261: 739–746
   Web of Science ®Google Scholar
• Chambard J., Paris S., L'Allemain G., Pouyssegur J. Two growth factor signalling pathways in fibrohlasts distinguished by pertussis toxin. Nature 1987; 326: 800–803
   PubMed Web of Science ®Google Scholar
• Scarborough R., Naughton M., Teng W., Hung D., Rose J., Vu T., Wheaton V., Turck C., Coughlin S. Tethered ligand agonist peptides: structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. Journal of Biological Chemistry 1992; 267: 13146–13149
   PubMed Web of Science ®Google Scholar
• Vassallo J. R. R., Kieber-Emmons T., Cichowski K., Brass L. F. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. Journal of Biological Chemistry 1992; 267: 6081–6085
   PubMed Web of Science ®Google Scholar
• Coller B. S., Ward P., Ceruso M., Scudder L. E., Springer K., Kutok J., Prestwich G. D. Thrombin receptor activating peptides: Importance of the N-terminal serine and its ionization state as judged by pH-dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopepti-dase. M. Biochemistry 1992; 31: 11713–11720
   Web of Science ®Google Scholar
• Bahou W., Kutok J., Wong A., Potter C., Coller B. Identification of a thrombin receptor sequence specifying activation-dependent responses. Blood 1994; 84: 4195–4202
   PubMed Web of Science ®Google Scholar
• Gerstzen R. E., Chen J., Ishii M., Ishii K., Wang L., Nanevicz T., Turck C. W., Vu T. H., Coughlin S. K. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Narure 1994; 368: 648–651
   PubMed Web of Science ®Google Scholar
• Bahou W., Coller B., Potter C., Norton K., Kutok J., Goligorsky M. The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. Journal of Clinical Investigation 1993; 91: 1405–1413
   PubMed Web of Science ®Google Scholar
• Ngaiza J., Jaffc E. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochemical Biophysical Research Communication 1991; 179: 1656–1661
   PubMed Web of Science ®Google Scholar
• Zhong C., Hayzer D., Corson M., Runge M. Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vivo regulation by basic fibroblast growth factor. Journal of Biological Chemistry 1992; 267: 16975–16979
   PubMed Web of Science ®Google Scholar
• Mari B., Imbert V., Belhacene N., Far D. F., Peyron J., Pouysségur J., Van Obberghen-Schilling E., Rossi B., Auberger P. Thrombin and thrombin receptor agonist peptide induce early events of T-cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. Journal of Biological Chemistry 1994; 269: 8517–8523
   PubMed Web of Science ®Google Scholar
• Hoffman M., Church F. C. Response of blood leukocytes to thrombin receptor peptides. Journal of Leukocyte Biology 1993; 54: 145–151
   PubMed Web of Science ®Google Scholar
• Zimmerman B. J., Arrhenius T. S., Gaeta F. C. A., Granger D. N. Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules: roles of P-selectin and sialyl Lewis X. American Journal of Physiology 1994; 267: H1049–H1053
   PubMed Web of Science ®Google Scholar
• Lau L. F., Pumiglia K., Cote Y. P., Feinstein M. B. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Biochemical Journal 1994; 303: 391–400
   PubMed Web of Science ®Google Scholar
• Mirza H., Yatsula V., Bahou W. F. The pro-teinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. Molecular characterization and evidence for functional coupling to the thrombin receptor. Journal of Clinical Investigation 1996; 97: 1705–1714
   PubMed Web of Science ®Google Scholar
• Santulli R. J., Derian C. K., Darrow A. U, Tomko K. A., Eckardt A. J., Seiberg M., Scarborough R. M., Andrade-Gordon P. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proceedings of the National Academy of Sciences USA 1995; 92: 9151–9155
   PubMed Web of Science ®Google Scholar
• Bohm S. K., Kong W. Y., Bromme D., Smeekens S. P., Anderson D. C., Connolly A., Kahn M., Nelken N. A., Coughlin S. R., Payan D. G., Bunnett N. W. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochemical Journal 1996; 314: 1009–1016
   PubMed Web of Science ®Google Scholar
• Connolly A. J., Ishihara H., Kahn M. L., Farese R. V., Coughlin S. R. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 38: 516–519
   Web of Science ®Google Scholar
• Kinlough-Rathbone R. L., Rand M. L., Packham M. A. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood 1993; 82: 103–106
   PubMed Web of Science ®Google Scholar
• Connolly T. M., Condra C., Feng D., Cook J. J., Straineri M. T., Reilly C. F., Nutt R. F., Gould R. J. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thrombosis and Haemostasis 1994; 72: 627–633
   PubMed Web of Science ®Google Scholar
• Bahou W. F., Nierman W. C., Durkin A. S., Potter C. L., Demetrick D. J. Chromosomal assignment of the human thrombin receptor gene: localization to region q13 of chromosome 5. Blood 1993; 82: 1532–1537
   PubMed Web of Science ®Google Scholar
• Nystedt S., Emilsson K., Larsson A. K., Strombeck B., Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. European Journal of Biochemistry 1995; 232: 84–89
   PubMedGoogle Scholar
• Schmidt V., Demetrich D., Bahou W. Genomic cloning and characterization of the human thrombin receptor gene: evidence for a novel gene family that includes PAR-2. Journal of Biological Chemistry 1996; 271: 9307–9312
   PubMed Web of Science ®Google Scholar
• van Leeuwen B. H., Martinson M. E., Webb G. C., Young I. G. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 1989; 73: 1142–1148
   PubMed Web of Science ®Google Scholar
• Rowen L., Koop B., Hood L. The complete 685-kilobase DNA sequence of the human β T-cell receptor locus. Science 1996; 272: 1755–1762
   PubMed Web of Science ®Google Scholar
• Jakobovits E. B., Schlokat U., Vannice J. L., Derynck R., Levinson A. D. The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence. Molecular Cell Biology 1988; 8: 5549–5554
   PubMed Web of Science ®Google Scholar
• Villa-Garcia M., Li L., Riely G., Bray P. F. Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene. Blood 1994; 83: 668–676
   PubMedGoogle Scholar
• Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annual Review of Biochemistry 1981; 50: 349–383
   PubMed Web of Science ®Google Scholar
• Martin D. I., Zon L. I., Mutter G., Orkin S. H. Expression of an erythroid transcription factor in megakary-ocytic and mast cell lineages. Nature 1990; 344: 444–447
   PubMed Web of Science ®Google Scholar
• Berghe Van Den H., LeBeau M., Benheim A. Fourth International Workshop on Chromosomes in Leukemia 1982: Deletion of 5q. Cancer Genetics and Cytogenetics 1984; 11: 296–299
   PubMedGoogle Scholar
• Mitelman F., Manolova Y., Manolova G., Billstrom R., Heims S., Kristofferson U., Mandahl N. Analysis of the 5q marker chromosome in refractory anemia. Hereditas 1986; 195: 49
   Google Scholar
• Pedersen B., Jensen I. M. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia 1991; 5: 566
   PubMed Web of Science ®Google Scholar
• Bellomo M. J., Parlier V., Mühlematter D., Grob J. P., Beris P. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genetics and Cytogenetics 1992; 59: 138–160
   PubMed Web of Science ®Google Scholar
• Foster D. C., Sprecher C. A., Grant F. J., Kramer J. M., Kuijper J. L., Holly R. D., Whitmore T. E., Heipel M. D., Bell L. A., Ching A. F. T., McGrane V., Hart C., O'Hara P. J., Lok S. Human thrombopoietin: Gene structure, cDNA sequence, expression, and chromosomal localization. Proceedings of the National Academy of Sciences USA 1994; 91: 13023–13027
   PubMed Web of Science ®Google Scholar
• Sohma Y., Akahori H., Seki N., Hori T., Ogami K., Kato T., Shimada Y., Kawamura K., Miyazaki H. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Letters 1994; 353: 57–61
   PubMed Web of Science ®Google Scholar
• Bouscary D., Fontenay-Roupie M., Chretien S., Hardy A. C., Viguié F., Picard F., Melle J., Dreyfus F. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome. British Journal of Haematology 1995; 91: 425–427
   PubMed Web of Science ®Google Scholar
• Suzukawa K., Satoh H., Taniwaki M., Yokota J., Morishita K. The human thrombopoietin gene is located on chromosome 3q26.33-q27, but is not transcription-ally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome). Leukemia 1995; 9: 1328–1331
   PubMed Web of Science ®Google Scholar
• Vittet D., Chevillard C. Thrombin interactions with cells of the megakaryocytic lineage. Blood Coagulation and Fibrinolysis 1993; 4: 759–768
   PubMed Web of Science ®Google Scholar
• Dorn G. W., III, Davis M. G. Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells. The Journal of Pharmacology and Experimental Therapeutics 1992; 262: 1242–1247
   PubMed Web of Science ®Google Scholar
• Vittet D., Mathieu M. N., Launay J. M., Chcvillard C. Thrombin inhibits proliferation of the human megakaryoblastic MEG-01 cell line: a possible involvement of a cyclic-AMP dependent mechanism. Journal of Cell Physiology 1992; 150: 65–75
   PubMed Web of Science ®Google Scholar
• Plantier J., Berthier R., Rival Y., Schweitzer A., Rabiet J. Evidence for a selective inhibitory effect of thrombin on megakaryocyte progenitor growth mediated by the thrombin receptor. British Journal of Haematology 1994; 87: 755–762
   PubMed Web of Science ®Google Scholar
• Demetrick D. J., Dewald G. W., Lanman J., Bahou W. F. The thrombin receptor gene is centromeric to the common proximal breakpoint in patients with the 5q-syndrome: identification of a previously unrecognized chromosome 5 inversion. British Journal of Haematology 1996; 92: 339–343
   PubMed Web of Science ®Google Scholar
• Mecucci C., Berghe Van Den H., Michaux J., Bosly A., Doyen C. Paracentric inversions on the long arm of chromosome 5 in secondary myelodysplastic disorders. Cancer Genetics and Cytogenetics 1987; 29: 171–173
   PubMed Web of Science ®Google Scholar